Kraj: Republika Południowej Afryki
Język: angielski
Źródło: South African Health Products Regulatory Authority (SAHPRA)
Lennon
INDICATIONS [/za_1264.html#1] [/za_1264.html#1] [/za_1264.html#1] CONTRA-INDICATIONS [/za_1264.html#1] [/za_1264.html#1] DOSAGE [/za_1264.html#1] [/za_1264.html#1] SIDE-EFFECTS [/za_1264.html#1] [/za_1264.html#1] PREGNANCY [/za_1264.html#1] OVERDOSE [/za_1264.html#1] IDENTIFICATION [/za_1264.html#1] [/za_1264.html#1] PATIENT INFORMATION HYOSPASMOL® TABLETS HYOSPASMOL® INJECTION SCHEDULING STATUS: S2 PROPRIETARY NAME (and dosage form): HYOSPASMOL ® TABLETS HYOSPASMOL ® INJECTION COMPOSITION: Each tablet contains: 10 mg HYOSCINE BUTYLBROMIDE (Hyoscine n-Butylbromide). Each mL of injection contains: 20 mg Hyoscine Butylbromide (Hyoscine n-Butylbromide). PHARMACOLOGICAL CLASSIFICATION: A 11.2 Gastro-intestinal antispasmodics. PHARMACOLOGICAL ACTION: Hyoscine butylbromide is a quaternary ammonium anticholinergic agent, the peripheral effects of which are similar to those of atropine, but weaker and of shorter duration. INDICATIONS: Hyoscine butylbromide is used in the treatment of conditions associated with gastro-intestinal spasm. CONTRA-INDICATIONS: Enlarged prostate. Closed angle glaucoma, or narrow angle between the iris and cornea as hyoscine increases intra- ocular pressure. WARNING: The safe use of Hyospasmol is contentious in patients with porphyria. DOSAGE AND DIRECTIONS FOR USE: ADULT DOSE: TABLETS: 20 mg four times daily. INJECTION: 20 mg i.m. or i.v., two or three times daily. PAEDIATRIC DOSE: TABLETS: Children 1 - 3 years: 5-10 mg three times daily. Children 3 - 6 years: 10 mg three times daily. Children 6 - 12 years: 10-20 mg three times daily. INJECTION: Infants and children up to 3 years: 5 mg i.m. or i.v., two or three times daily. Children 3 - 12 years: 10 mg i.m. or i.v., two or three times daily. SIDE-EFFECTS AND SPECIAL PRECAUTIONS: Dryne Przeczytaj cały dokument